Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02094846
Other study ID # Evaluation with cell phones
Secondary ID
Status Completed
Phase N/A
First received March 4, 2014
Last updated March 20, 2014
Start date October 2012
Est. completion date May 2013

Study information

Verified date March 2014
Source Instituto Nacional de Salud Publica, Mexico
Contact n/a
Is FDA regulated No
Health authority Mexico: National Institute of Public Health, Health Secretariat
Study type Interventional

Clinical Trial Summary

The aim of the study was to assess the effect of an individualized intervention based on cell phones to improve glycemic control in patients with type 2 diabetes attending Epidemiology Research Unit in Cuernavaca, Morelos. Mexico


Description:

In this study before randomization, the participants received workshops on diet, physical activity, glycemic index of foods.

Bandura´s theoretical model was used in the voice messages sent to the intervention group.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date May 2013
Est. primary completion date February 2013
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 69 Years
Eligibility Inclusion Criteria:

- type 2 diabetes mellitus > 10 years

- Glycated hemoglobin >7%

Exclusion Criteria:

- Take insulin regularly

- Pregnant woman

- Woman who expected to be pregnant the next 6 months

- 24 hrs creatinine < 30 ml/minute

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Behavioral:
Voice messages
Voice messages reinforced with self-efficacy

Locations

Country Name City State
Mexico Unidad de Investigación en Epidemiología y Servicios de Salud del Instituto Mexicano del Seguro Social Cuernavaca Morelos

Sponsors (1)

Lead Sponsor Collaborator
Instituto Nacional de Salud Publica, Mexico

Country where clinical trial is conducted

Mexico, 

References & Publications (3)

Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32:56-69. doi: 10.1093/epirev/mxq004. Epub 2010 Mar 30. Review. — View Citation

Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, Huang J, Wang L, Gu D. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011 Apr;28(4):455-63. doi: 10.1111/j.1464-5491.2010.03180.x. — View Citation

Oh JA, Kim HS, Yoon KH, Choi ES. A telephone-delivered intervention to improve glycemic control in type 2 diabetic patients. Yonsei Med J. 2003 Feb;44(1):1-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Glycated hemoglobin Glycated hemoglobin is obtained from a blood sample at the beginning of the study and 3 months later. Basal and 3 months No
Secondary Low Density Lipoprotein Low Density Lipoprotein is obtained from a blood sample at the beginning of the study and 3 months later. Basal and 3 months No
Secondary High Density Lipoprotein High Density Lipoprotein is obtained from a blood sample at the beginning of the study and 3 months later. Basal and 3 months No
Secondary Cholesterol Cholesterol is obtained from a blood sample at the beginning of the study and 3 months later. Basal and 3 months No
Secondary Self-efficacy Self-efficacy questionnaire is divided into a diet´s self-efficacy questionnaire and physical activity´s self-efficacy questionnaire.
People can obtained "low self-efficacy" status or "high self-efficacy" status
Basal and 3 months No
Secondary Physical activity A triaxial accelerometer was used, colocated on the hip and the participants were supposed to use it 7 days for a minimal of 10 hours per day Basal and 3 months No
See also
  Status Clinical Trial Phase
Completed NCT02771093 - An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus Phase 4
Completed NCT02545842 - Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL) Phase 4
Recruiting NCT03436212 - Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump. N/A
Completed NCT03244800 - A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus. Phase 2
Completed NCT03960424 - Diabetes Management Program for Hispanic/Latino N/A
Withdrawn NCT02769091 - A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes Phase 2
Recruiting NCT06065540 - A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor Phase 3
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT04091373 - A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide Phase 1
Completed NCT03296800 - Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects Phase 1
Recruiting NCT06212778 - Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
Completed NCT05979519 - Fresh Carts for Mom's to Improve Food Security and Glucose Management N/A
Recruiting NCT05579314 - XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Terminated NCT03684642 - Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Phase 3
Completed NCT03248401 - Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Phase 4
Completed NCT03644134 - A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns N/A
Completed NCT05295160 - Fasting-Associated Immune-metabolic Remission of Diabetes N/A
Completed NCT02836873 - Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment Phase 3
Completed NCT02252224 - Forxiga (Dapagliflozin) Regulatory Postmarketing Surveillance